Virtual Presentation

Active Management of Oral Nucleos(t)ide Analogue Therapy for Hepatitis B

Source: On-Treatment Management Strategies for Chronic Hepatitis B

Active Management of Oral Nucleos(t)ide Analogue Therapy for Hepatitis B


Faculty:

  • Ira M. Jacobson, MD

CME CREDIT INFORMATION

Release Date: 03/24/08

Expiration Date: 03/23/09


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.1 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize data showing the relationships between early responses to oral anti–hepatitis B virus agents and future treatment outcomes
  • Discuss the importance of Week 12 and 24 virologic monitoring in making on-treatment decisions for hepatitis B in patients receiving oral therapy
  • Recount the on-treatment definitions of response in hepatitis B and differential management strategies based on treatment response

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.